Intuitive Surgical, Inc. (NASDAQ:ISRG) had its target price hoisted by equities researchers at Stifel Nicolaus from $800.00 to $850.00 in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Stifel Nicolaus’ target price indicates a potential upside of 4.36% from the stock’s previous close.
Several other analysts also recently issued reports on ISRG. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, December 21st. Evercore ISI downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price target for the company. in a report on Wednesday, January 4th. Wedbush reiterated an “outperform” rating and issued a $800.00 price target on shares of Intuitive Surgical in a report on Saturday, January 14th. Canaccord Genuity reiterated a “buy” rating on shares of Intuitive Surgical in a report on Wednesday, January 25th. Finally, Bank of America Corp set a $800.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Tuesday, February 14th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $771.97.
Intuitive Surgical (NASDAQ:ISRG) traded up 0.84% during midday trading on Wednesday, reaching $814.45. The company’s stock had a trading volume of 394,361 shares. The stock has a market capitalization of $31.59 billion, a PE ratio of 43.48 and a beta of 0.55. Intuitive Surgical has a 52 week low of $610.71 and a 52 week high of $817.20. The firm’s 50-day moving average price is $754.32 and its 200-day moving average price is $693.30.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, topping analysts’ consensus estimates of $3.97 by $1.12. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The business earned $674.20 million during the quarter, compared to the consensus estimate of $664.72 million. During the same period in the prior year, the firm posted $4.42 EPS. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical will post $23.49 earnings per share for the current year.
In other news, CFO Marshall Mohr sold 2,000 shares of the stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $700.00, for a total transaction of $1,400,000.00. Following the transaction, the chief financial officer now owns 3,289 shares of the company’s stock, valued at $2,302,300. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lonnie M. Smith sold 1,000 shares of the stock in a transaction dated Friday, January 27th. The stock was sold at an average price of $684.38, for a total transaction of $684,380.00. Following the transaction, the director now directly owns 234,971 shares in the company, valued at approximately $160,809,452.98. The disclosure for this sale can be found here. Insiders have sold 34,118 shares of company stock worth $25,064,571 in the last ninety days. Corporate insiders own 3.10% of the company’s stock.
Several institutional investors have recently modified their holdings of ISRG. Acropolis Investment Management LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $115,000. Bessemer Group Inc. boosted its position in shares of Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 96 shares during the last quarter. Huntington National Bank boosted its position in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the last quarter. Stephens Inc. AR boosted its position in shares of Intuitive Surgical by 77.1% in the third quarter. Stephens Inc. AR now owns 255 shares of the medical equipment provider’s stock valued at $185,000 after buying an additional 111 shares during the last quarter. Finally, Koch Industries Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $205,000. 91.16% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2064991/intuitive-surgical-inc-isrg-given-buy-rating-at-stifel-nicolaus.html
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.